Envestnet Asset Management’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Buy
361,667
+44,147
+14% +$1.36M ﹤0.01% 1846
2026
Q1
$9.09M Buy
+317,520
New +$9.25M ﹤0.01% 1890
2022
Q1
Sell
-38,595
Closed -$825K 4042
2021
Q4
$825K Buy
38,595
+16,700
+76% +$350K ﹤0.01% 2747
2021
Q3
$441K Buy
21,895
+6,138
+39% +$126K ﹤0.01% 3041
2021
Q2
$318K Buy
+15,757
New +$315K ﹤0.01% 3248

Other funds holding REVS

Envestnet Asset Management's REVS Position: Q2 2026 in Review

Envestnet Asset Management increased its Columbia Research Enhanced Value ETF (REVS) stake by 14% in Q2 2026, buying an estimated $1.36M and bringing the position to 361,667 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Envestnet Asset Management first reported a position in REVS in Q2 2021 and has held it in 5 quarters since. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Envestnet Asset Management held 361,667 shares of Columbia Research Enhanced Value ETF worth $11.4M as of Q2 2026.
  • Envestnet Asset Management bought 44,147 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $1.36M.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1846 holding.
  • Envestnet Asset Management first reported a position in Columbia Research Enhanced Value ETF in Q2 2021 and has held it in 5 quarters since.
  • 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.